ABIOMED Becomes Oversold (ABMD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of ABIOMED, Inc. ( ABMD) entered into oversold territory, hitting an RSI reading of 28.4, after changing hands as low as $19.936 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 55.7. A bullish investor could look at ABMD's 28.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ABMD shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

ABIOMED, Inc. 1 Year Performance Chart

Looking at the chart above, ABMD's low point in its 52 week range is $11.80 per share, with $25.25 as the 52 week high point — that compares with a last trade of $19.99.

According to the ETF Finder at ETF Channel, ABMD makes up 1.47% of the SPDR S&P Health Care Equipment ETF ( XHE) which is trading lower by about 0.1% on the day Monday.
null

If you liked this article you might like

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

Closing the Door on Abiomed

Closing the Door on Abiomed

Capturing Profits on AIG

Capturing Profits on AIG

A Roundup of My Open Positions

A Roundup of My Open Positions

Pumped Up About Abiomed Collar Play

Pumped Up About Abiomed Collar Play